Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

Octapharma

Status: Completed

Conditions: Von Willebrand Disease

Treatments: Other: Patients using Wilate as standard of care

Study type: Observational

Funder types: Industry

Identifiers

NCT01602419

Wil-20

Details and patient eligibility

About

This is an observational study, hence there is no study hypothesis

Enrollment: 120 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with a diagnosis of von Willebrand Disease who have been prescribed Wilate

Trial design

120 participants in 1 patient group

Patients using Wilate as standard of care treatment

Description:

This patient population is being treated with Wilate as standard of care treatment

Treatment:

Other: Patients using Wilate as standard of care